Effects of additional blood pressure and lipid measurements on the prediction of cardiovascular risk

被引:16
作者
Bell, Katy [1 ]
Hayen, Andrew [1 ]
McGeechan, Kevin [1 ]
Neal, Bruce [1 ]
Irwig, Les [1 ]
机构
[1] Univ Sydney, Sydney, NSW 2006, Australia
基金
英国医学研究理事会;
关键词
Blood pressure; cardiovascular diseases; cholesterol; reproducibility of results; risk assessment; risk factors; CORONARY-HEART-DISEASE; SCORE; VARIABILITY; BIOMARKERS; EVENTS; STROKE;
D O I
10.1177/1741826711424494
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Current guidelines recommend that decisions to start preventative therapy for cardiovascular disease (CVD) should be based on absolute risk; however, current risk equations are based on single measurements of risk factors. We aimed to assess whether two measurements of blood pressure and lipids improves the prediction of cardiovascular risk compared to one measurement. Methods and results: We used sex-specific Cox proportional hazards models to evaluate the risk of first CVD event in 2385 participants of the Framingham Offspring Study attending both the second and third visits. We estimated the effects on risk prediction of using the average of two measurements of blood pressure, total cholesterol, and HDL cholesterol compared to using one measurement of the risk factors. We found that these risk factors were each markedly more predictive of CVD when the average of two measurements was used rather than one measurement and age was less predictive of CVD. There were small improvements in the overall model fit, discrimination, and calibration. Reclassification also showed small improvements across the risk spectrum (net reclassification information, NRI, for women 3.0%, 95% CI - 0.9 to 24.8%; NRI for men 4.0%, 95% CI - 2.2 to 14.1%) and possibly greater improvements for intermediate-risk individuals (NRI for women 32.3%, 95% CI - 21.9 to 46.8%; NRI for men 16.0%, 95% CI - 3.3 to 43%). Conclusions: Averaging two measurements of blood pressure and lipids results in marked increases in the predictiveness of these risk factors and smaller improvements in the overall prediction of cardiovascular risk including reclassification.
引用
收藏
页码:1474 / 1485
页数:12
相关论文
共 31 条
[1]  
[Anonymous], GUID ASS ABS CARD DI
[2]   Use of randomised trials to decide when to monitor response to new treatment [J].
Bell, Katy J. L. ;
Irwig, Les ;
Craig, Jonathan C. ;
Macaskill, Petra .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7640) :361-365
[3]   Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor-Based Regimens An Individual Patient Data Meta-Analysis From Randomized, Placebo-Controlled Trials [J].
Bell, Katy J. L. ;
Hayen, Andrew ;
Macaskill, Petra ;
Craig, Jonathan C. ;
Neal, Bruce C. ;
Fox, Kim M. ;
Remme, Willem J. ;
Asselbergs, Folkert W. ;
van Gilst, Wiek H. ;
MacMahon, Stephen ;
Remuzzi, Giuseppe ;
Ruggenenti, Piero ;
Teo, Koon K. ;
Irwig, Les .
HYPERTENSION, 2010, 56 (03) :533-U429
[4]   Mixed models showed no need for initial response monitoring after starting antihypertensive therapy [J].
Bell, Katy J. L. ;
Hayen, Andrew ;
Macaskill, Petra ;
Craig, Jonathan C. ;
Neal, Bruce C. ;
Irwig, Les .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2009, 62 (06) :650-659
[5]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[6]  
Cupples LA, 1987, FRAMINGHAM HEART STU
[7]   General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753
[8]   The things to come of SHAPE: Cost and effectiveness of cardiovascular prevention [J].
Diamond, George A. ;
Kaul, Sanjay .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (07) :1013-1015
[9]   Monitoring cholesterol levels: Measurement error or true change? [J].
Glasziou, Paul P. ;
Irwig, Les ;
Heritier, Stephane ;
Simes, R. John ;
Tonkin, Andrew .
ANNALS OF INTERNAL MEDICINE, 2008, 148 (09) :656-661
[10]   European guidelines on cardiovascular disease prevention in clinical practice: Executive summary [J].
Graham, Ian ;
Atar, Dan ;
Borch-Johnsen, Knut ;
Boysen, Gudrun ;
Burell, Gunilla ;
Cifkova, Renata ;
Dallongeville, Jean ;
De Backer, Guy ;
Ebrahim, Shah ;
Gjelsvik, Bjorn ;
Herrman-Lingen, Christoph ;
Hoes, Arno ;
Humphries, Steve ;
Knapton, Mike ;
Perk, Joep ;
Priori, Silvia G. ;
Pyorala, Kalevi ;
Reiner, Zeljko ;
Ruilope, Luis ;
Sans-Menendez, Susana ;
Reimer, Wilma Scholte Op ;
Weissberg, Peter ;
Wood, David ;
Yarnell, John ;
Zamorano, Jose Luis .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2007, 14 :E1-E40